Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.
The effects of levamisole on the immune of cytotoxic thymus-derived lymphocytes were studied. An optimum relative dose of antigen and and lavamisole appears to be crucial for levamisole to augment development of cytotoxic cells.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D003601:Cytotoxicity Tests, Immunologic; D004306:Dose-Response Relationship, Immunologic; D007111:Immunity, Cellular / Q000187:drug effects*; D007978:Levamisole / Q000008:administration & dosage / Q000494:pharmacology*; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects*
D000951:Antigens, Neoplasm; D007978:Levamisole